China is rapidly overtaking the US in global oncology clinical trials, accounting for more than half of late-stage study activity by 2025.

J&J's MonumenTAL-6 results add to the growing body of evidence touting Talvey and Tecvayli’s use in earlier multiple myeloma treatment lines.

Eli Lilly is set for another win in the glucagon-like peptide-1 (GLP-1) sector as its triple-g agonist, retatrutide, has succeeded in type 2 diabetes and obesity. Marking the four ...

Participants in SHASTA-3 and SHASTA-4 received 25mg of plozasiran via subcutaneous injection every three months. Credit: YURIMA / Shutterstock.com. Arrowhead Pharmaceuticals has reported top line ...

The funds will help Crystalys progress its clinical-stage development efforts and commercialisation plans for its gout drug, dotinurad.

Celldex is discontinuing its Phase II study on barzolvolimab in prurigo nodularis. Credit: ychornobryvets / Shutterstock.com. Celldex’s subcutaneous monoclonal antibody (mAb) has failed to show ...

The study examines the safety, tolerability, and preliminary anti-tumour activity of IPH4502 in Nectin-4 expressing tumours. Credit: Gorodenkoff / Shutterstock.com. French company Innate Pharma has ...

Devonian Health Group has received authorisation from Health Canada for its CTA to begin a Phase II/III study of Thykamine cream to treat mild-to-moderate atopic dermatitis in paediatric patients.

Phase I accounts for approximately 43.6% of all Alzheimer’s disease trials, highlighting a strong influx of early stage candidates entering the pipeline. Credit: Only_NewPhoto via Shutterstock.com.